About Pancreatic Cancer
In regards to Pancreatic Cancer, there is hope.
Many agencies, research facilities, researchers, and activists are becoming more unified under the common goal or irradicating this terrible disease. As a result, patients facing the disease today are being given new opportunities to extend and improve their lives.
For example, in 2018, Immunovia brought together researchers from Harvard and Yale to present at an event at Fenway Park in Boston on what’s currently being done to improve Pancreatic Cancer patient outcomes.
Dr. James Farrell, Director of the Yale Center for Pancreatic Diseases at Yale New Haven Hospital and Professor of Medicine at Yale School of Medicine, and Dr. A. James Moser, Co-Director of the Pancreas and Liver Institute at Beth Israel Deaconess Medical Center and Associate Professor of Surgery at Harvard Medical School were the featured presenters. Both provided perspectives on the role early detection can have on improving survival rates.
However, there is still much work that still needs to be done.
As reported by the Pancreatic Cancer Action Network:
“Deaths caused by pancreatic cancer surpassed breast cancer a few years ago, and pancreatic cancer remains on track to overtake colorectal cancer to move to the second leading cause of cancer-related deaths in the United States around 2020.”
Our goal here on this page is to show what progress is being made in Pancreatic Cancer Research and to help those who may have been recently diagnosed.